SION — Sionna Therapeutics Share News
0.000.00%
Last trade - 00:00- $162.76m
- -$48.27m
Brief: Sionna Therapeutics Appoints Caroline Stark Beer As Chief Business Officer
Brief: Sionna Therapeutics Announces Positive Phase 1 Data For Nbd1 Stabilizers Sion-719 And Sion-451 And Advances Both Programs In Clinical Development For Cystic Fibrosis
Brief: Sionna Therapeutics Phase 1 Topline Data For Nbd1 Stabilizers Sion-719 & Sion-451 Expected This Quarter
U.S. RESEARCH ROUNDUP-Accolade, Crowdstrike, Marriott International
Brief: Atlas Venture Fund Xi L.P Reports 6.5% Stake In Sionna Therapeutics As Of Feb 10
Brief: Orbimed Advisors Llc Reports 8.4% Stake In Sionna Therapeutics As Of Feb 10 - SEC Filing
U.S. STOCKS ON THE MOVE-McDonald, Uber, SolarWinds
Sionna Therapeutics jumps nearly 40% in cracking Nasdaq debut
Sionna Therapeutics set to open 50% above offer price after upsized $191 mln IPO
Sionna Therapeutics set to open nearly 40% above offer price after upsized $191 mln IPO
Sionna Therapeutics set to open 33% above offer price after upsized $191 mln IPO
Brief: Sionna Therapeutics Prices Upsized IPO Of 10.6 Mln Shares At $18/Share